| Ytd | 23.23% | |
| 1y | 49.44% |
| Open | 123.97 | Prev Close | 123.94 | Low | 123.95 | High | 123.99 | Mkt Cap | 9.13B |
| Vol | 0.00 | Avg Vol | 2.33M | EPS | -5.69 | P/E | -21.79 | Forward P/E | -29.99 |
| Beta | 1.14 | Short Ratio | 0.56 | Inst. Own | 113.30% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 112.22 | 200-d Avg | 103.43 | 1yr Est | 124.00 |
NUVL News
Fifth Third Bancorp bought a new position in shares of Nuvalent, Inc. (NASDAQ: NUVL) during the firs
BALA CYNWYD, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi
BALA CYNWYD, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swic
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Nuvalent (NASDAQ: NUVL) for
BALA CYNWYD, Pa., June 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi
Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 202
Top Wall Street analysts changed their outlook on top names. See all analyst rating changes, includi
Top Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See
Pre-Market Stock Futures: Futures are trading higher this morning, but if you've ever heard the old
Bernstein analyst Jeffrey Walch downgrades Nuvalent (NASDAQ:NUVL) from Outperform to Market Perfo
MONSEY, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
During market turbulence, investors turn to dividend-yielding stocks. Benzinga offers latest analyst
The sudden $10.6 billion acquisition of Nuvalent NASDAQ: NUVL by GSK NYSE: GSK violently shatters a
GSK's record $10.6 billion deal for U.S. company Nuvalent will accelerate the British drugmaker's re
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Publi
MILWAUKEE, June 10, 2026 /PRNewswire/ -- Ademi LLP is investigating Nuvalent (NASDAQ: NUVL) for poss
Top analysts changed outlook on top names, including downgrades, upgrades, and initiations. Check ou
GSK PLC's (LSE:GSK, NYSE:GSK) $10.6 billion (£8bn) acquisition of US biotech Nuvalent has achieved s
Pre-Market Stock Futures: Futures are trading lower after the stock market tried to take a cue from
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
The Nasdaq 100 sank 3.3% Tuesday as AI and optical stocks cratered, while cash rotated into real est
GSK buys Nuvalent for $10.6 billion, adding three lung cancer pipeline candidates and expanding its
US stocks down, Dow Jones drops 300 points. Real estate shares up, technology stocks down. U.S. trad
US stocks higher, Dow Jones index up 300 points on strong earnings and sales guidance from J.M. Smuc
Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Anal
GSK will acquire Nuvalent for $10.6 billion to expand its lung cancer pipeline as Nuvalent shares su
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT
Multi-product oncology deal for assets that have validated targets and aim to address efficacy and/o
During Thursday, 849 stocks hit new 52-week lows.
On Friday, 431 companies hit new 52-week lows.